drugset / Trial / NCT01282619
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The main purpose of this study is to evaluate the safety and efficacy of Huperzine A sustained release tablets in patients with mild to moderate Alzheimer's Disease.
Timeline
- Start
- 2010-05
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 200 ug | — |
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 400 ug | — |